Madrigal Pharmaceuticals, Inc. Share Price
Stocks
MDGL
US5588681057
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 510.04 USD | -0.06% |
|
+9.14% | -12.42% |
| 30/07 | Madrigal Pharmaceuticals Q2 Loss Widens, Revenue Increases | MT |
| 30/07 | Madrigal Pharmaceuticals, Inc., Q2 2026 Earnings Call, Jul 30, 2026 |
| Market Cap | 1.18TCr 1.02TCr 951.89Cr 873.22Cr 1.64TCr 1,12200Cr 1.67TCr 11TCr 4.38TCr 56TCr 4.43TCr 4.33TCr 1,85800Cr | P/E 2026 * |
-80.8x | P/E 2027 * | 81x |
|---|---|---|---|---|---|
| Enterprise Value | 1.13TCr 973.95Cr 909.52Cr 834.35Cr 1.57TCr 1,07200Cr 1.59TCr 11TCr 4.19TCr 54TCr 4.23TCr 4.14TCr 1,77600Cr | EV / Sales 2026 * |
7.38x | EV / Sales 2027 * | 5.05x |
| Free-Float |
94.13% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Madrigal Pharmaceuticals, Inc.
| 1 day | -0.06% | ||
| 1 week | +9.14% | ||
| Current month | +9.14% | ||
| 1 month | -6.48% | ||
| 3 months | -4.64% | ||
| 6 months | +6.79% | ||
| Current year | -12.42% |
| 1 week | 461.25 |  | 524.45 |
| 1 month | 447.01 | | 569.44 |
| Current year | 416.21 | | 598.79 |
| 1 year | 342.73 | | 615 |
| 3 years | 119.76 | | 615 |
| 5 years | 52.33 | | 615 |
| 10 years | 7.27 | | 615 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Sibold
CEO | Chief Executive Officer | 59 | 08/09/2023 |
Mardi Dier
DFI | Director of Finance/CFO | 62 | 11/03/2024 |
David Soergel
CTO | Chief Tech/Sci/R&D Officer | 58 | 21/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Rebecca Taub
BRD | Director/Board Member | 74 | 01/07/2016 |
Richard Levy
BRD | Director/Board Member | 68 | 11/08/2016 |
James Daly
BRD | Director/Board Member | 64 | 27/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/07/26 | Sell | Chief Executive Officer | -2,500 | 0.0108% | ||
| 17/06/26 | Free | Director | 1,220 | 0.0053% | ||
| 23/02/26 | Fiscal year | Director | 5,000 | 0.0220% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.06% | +9.14% | +49.01% | +184.16% | 1.18TCr | |
| +8.49% | +20.55% | +69.74% | +109.30% | 6.81TCr | |
| +1.25% | +2.44% | +32.55% | +72.63% | 5.52TCr | |
| -1.09% | +32.96% | +19.95% | +499.45% | 2.86TCr | |
| +2.72% | +3.41% | -15.88% | -4.90% | 2.35TCr | |
| +10.83% | +18.38% | +52.76% | +4.58% | 2.4TCr | |
| +6.50% | +7.56% | +38.20% | -21.33% | 1.84TCr | |
| -3.88% | +16.98% | +199.30% | +354.30% | 1.58TCr | |
| +6.20% | +11.51% | +34.94% | +681.88% | 1.64TCr | |
| +3.58% | +1.96% | +44.61% | +167.01% | 1.34TCr | |
| Average | +3.45% | +11.43% | +52.52% | +204.71% | 2.75TCr | |
| Weighted average by Cap. | +4.17% | +12.93% | +49.46% | +169.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 152.63Cr 132.02Cr 123.29Cr 113.1Cr 212.73Cr 15TCr 216.11Cr 1.45TCr 567.75Cr 7.28TCr 573.15Cr 560.61Cr 24TCr | 214.49Cr 185.53Cr 173.26Cr 158.94Cr 298.95Cr 20TCr 303.69Cr 2.03TCr 797.85Cr 10TCr 805.45Cr 787.82Cr 34TCr |
| Net income | -18Cr -16Cr -15Cr -14Cr -26Cr -1.75TCr -26Cr -174.26Cr -68Cr -877.09Cr -69Cr -68Cr -2.9TCr | 20Cr 17Cr 16Cr 15Cr 28Cr 1.9TCr 28Cr 189.54Cr 74Cr 954.03Cr 75Cr 73Cr 3.15TCr |
| Net Debt | -52Cr -45Cr -42Cr -39Cr -73Cr -4.99TCr -74Cr -497.1Cr -195.11Cr -2.5TCr -196.97Cr -192.66Cr -8.27TCr | -94Cr -82Cr -76Cr -70Cr -131.46Cr -8.98TCr -133.55Cr -893.92Cr -350.86Cr -4.5TCr -354.2Cr -346.44Cr -15TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/26/07 | $510.04 | -0.06% | 3,47,529 |
| 06/26/06 | $510.36 | -0.73% | 2,96,763 |
| 05/26/05 | $514.12 | +1.29% | 3,49,534 |
| 04/26/04 | $507.56 | +5.30% | 4,42,367 |
| 03/26/03 | $482.00 | +3.14% | 4,63,916 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MDGL Stock
Select your edition
All financial news and data tailored to specific country editions
